Corrigendum to "Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients". [Int J Antimicrob Agents 51 (2018) 594-600].
Sign Up to like & getrecommendations! Published in 2019 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2019.07.022
Abstract: The authors regret that in the manuscript under the section 2.3 Study Protocol, the following is written: “This dose was either decreased or increased based on the patient's kidney function ( 200 mL/min: 24/3 g/24h)”… read more here.
Keywords: piperacillin critically; continuous infusion; corrigendum population; population pharmacokinetics ... See more keywords
Population pharmacokinetics of continuous infusion piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa.
Sign Up to like & getrecommendations! Published in 2021 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2021.106408
Abstract: Continuous infusion (CI) piperacillin/tazobactam is frequently used to treat infections in very elderly patients. The aims is to conduct a population pharmacokinetic analysis of CI piperacillin/tazobactam and to identify optimal dosages for safe and effective… read more here.
Keywords: permissible doses; continuous infusion; piperacillin; piperacillin tazobactam ... See more keywords